Generic Business Overview
Barr Pharmaceuticals, Inc.
markets generic pharmaceuticals in more than 30 countries, including
the following key countries: United States, Canada, Croatia, Germany, Poland, and Russia.
Barr Laboratories, Inc.
Barr Laboratories, Inc., the U.S.
generic pharmaceutical subsidiary, develops, manufactures and markets more than 120 generic
pharmaceuticals in five core therapeutic categories: female healthcare, oncology, cardiovascular,
anti-infective and psychotherapeutic pharmaceuticals.
PLIVA d.d. and its Subsidiaries
PLIVA d.d., headquartered in Zagreb, Croatia,
serves as the European headquarters of Barr Pharmaceuticals. PLIVA has a portfolio of more than 1,025
branded generic products that compete in the key markets of Croatia, Germany, Poland and Russia, and
includes solid dose forms, injectables, creams/ointments, over-the-counter (OTC) products, cytostatics,
and active pharmaceutical ingredients (APIs). PLIVA is listed on the London and Zagreb Stock Exchanges.
Product Guide 
